chat
The Courage to Face COVID-19
*The opinions expressed by the hosts and guests in this show are not necessarily the views of Children’s Health Defense.
Resources
‘The Courage to Face COVID-19’ by Dr. Peter McCullough
‘Courageous Discourse’ With Dr. Peter McCullough + John Leake
Dr. Peter A. McCullough, MD, MPH
Use of Ivermectin in Hospitalized Patients With COVID-19
Nearly 90% Covid-19 Patients Put on Ventilators in New York Hospitals Died, Shows Study
Dr. McCullough with Joe Rogan: Pandemic Grand Rounds for the Public
Dr. Rick Bright Joins The Rockefeller Foundation to Lead Pandemic Prevention Institute Development
FDA on Twitter: You are not a horse. You are not a cow. Seriously, y'all. Stop it.
WHO recommends against the use of remdesivir in COVID-19 patients
Weber Shandwick Provides PR for Moderna and Pfizer, While Staffing the CDC’s Vaccine Office
Let's Declare a Pandemic Amnesty
The Wellness Company: Acute Care
Moderna Snags $25M DARPA Grant to Fight Pandemics With mRNA Drugs
Pfizer-BioNTech COVID-19 Vaccines
Coalition for Epidemic Preparedness Innovations (CEPI): Preliminary Business Plan 2017-2021
‘Cold a Long Time’: An Alpine Mystery
Bill Gates predicts world completely back to normal by end of 2022
Senate Hearing on COVID-19 Outpatient Treatment
Members of the Coronavirus Task Force Hold a Press Briefing, March 19, 2020
The Case Against Pfizer, A Record $2.3 Billion Settlement
Judge Says Microsoft Broke Antitrust Law
Bill & Melinda Gates Foundation
CNBC: He calls "The Godfather" his “favorite book of philosophy."
Alain Merieux & family Net Worth
Former FDA Commissioner Scott Gottlieb joins Pfizer board
Former FDA Commissioner Stephen Hahn joins venture capital group behind Moderna
Emergency Use Authorizations During the COVID-19 Pandemic
ICU and ventilator mortality among critically ill adults with COVID-19
bioMerieux Clinical Diagnostics: About Us
Inside the Chinese lab poised to study world's most dangerous pathogens
bioMerieux Clinical Diagnostics
Moderna offers NIH co-ownership of COVID vaccine patent amid dispute with government
